you have misunderstood my question.
I’m not asking if COH are doing drug discovery as thats obviously going to be way behind bisantrene. What I am asking is if they go into clinical testing and it doesn’t perform as it did in preclinical trials for FTO do they still have the ability to modify the drug to make it work or do they need to start from scratch.
Perhaps this is a more science ended question geared towards Dr Tendies.
you have misunderstood my question.I’m not asking if COH are...
-
- There are more pages in this discussion • 2,584 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.81 |
Change
-0.010(0.55%) |
Mkt cap ! $307.3M | |||
| Open | High | Low | Value | Volume |
| $1.83 | $1.84 | $1.78 | $271.2K | 150.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.81 | 349 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |